ERBB2 and breast cancer: As different receptor-defined subtypes of breast cancers exhibit distinct expression patterns, we split TCGA breast cancer samples into the four classical subtypes32,33: luminal A, luminal B, HER2-enriched, and basal-like, and then compared the transcriptomic profiles between the MFP and the CP tumors within each subtype.